AbbVie Inc., (NYSE:ABBV) a leading healthcare entity listed on S&P 500 Chart index, recently saw a shift in institutional ...

Following the release of upbeat data and given some recent signs of stabilization in the stocks, MarketWatch took at look at companies in the healthcare sector that are expected to produce the fastest ...

Novo Nordisk announces that CVS Caremark®, the country's largest PBM, has decided Wegovy® will be the preferred GLP-1 ...

Xiangxiang Ma, a partner of Anjie Broad Law Firm, explores the various ways in which a recent U.S. executive order on drug pricing is impacting Chinese pharmaceutical companies’ license-out model ...

AbbVie (ABBV) continued gains for seven straight sessions of gains, as the stock closed higher Friday. The North ...

Emrelis wins FDA approval, marking ABBV's first lung cancer drug and strengthening its oncology reach into solid tumors.

Gov. JB Pritzker named Doug Peterson, the director of AI strategy and implementation for Chicago-based pharmaceutical company ...

The Dividend Aristocrats are a group of 69 stocks in the S&P 500 Index with over 25 consecutive years of dividend increases. These high-quality businesses have managed recessions and various crises, ...

Edelson Lechtzin LLP announced that it has initiated an inquiry into whether the healthcare technology company, Semler ...

AnaptysBio, Inc.'s rosnilimab shows promise in RA & ulcerative colitis, targeting $20B+ markets. Phase 2b results highlight ...

For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased ...

Cardiovascular disease and mental illness commonly co-occur. Addressing them together can improve both mental health and ...